ライフサイエンスコーパス: galactosidase

1 rference with the enzymatic activity of beta-galactosidase.

2 a prodrug converted into Daunorubicin by ss-galactosidase.

3 mobilization and controlled released of beta-galactosidase.

4 nzymatic hydrolisis by Escherichia coli beta-galactosidase.

5 ymatic assays confirmed its activity of beta-galactosidase.

6 eptococcus, a bacterial surface-exposed beta-galactosidase.

7 at 95% lactose depletion for K. lactis beta-galactosidase.

8 lective artificial protein receptor for beta-galactosidase.

9 ne was replaced by n-LacZ gene encoding beta-galactosidase.

10 nanocomposites bound Aspergillus oryzae beta-galactosidase.

11 support for the immobilization of model beta-galactosidases.

12 ity-based probes that target retaining alpha-galactosidases.

13 inetic binding studies with substituted beta-galactosidases.

14 erization is not a universal feature of beta-galactosidases.

15 c hydrolysis of lactose by supplemental beta-galactosidases.

16 We discovered that plant-secreted beta-galactosidase 1 (BGAL1) of Nicotiana benthamiana promote

17 idase 1 (Neu1), neuraminidase 3 (Neu3), beta-galactosidase 1 (Glb1), and hexosaminidase B (HexB), pos

18 romoter of the pectin-metabolizing gene beta-GALACTOSIDASE 1 (RhBGLA1), and reduced expression of RhB

19 ted in Niemann Pick disease type A, and beta galactosidase-1, which is mutated in GM1 gangliosidosis.

20 nnanase (1021), endo-xylanase (1 9 1), alpha-galactosidase (3.42), beta-xylosidase (0.07) and beta-gl

21 ution for pyruvate kinase (232 kDa) and beta-galactosidase (466 kDa), extending the limits of isotopi

22 ly, no method is available to identify alpha-galactosidase A (agalA) mutations determining clinically

23 omal storage disease caused by loss of alpha galactosidase A (alpha-Gal A) activity and is characteri

24 d lysosomal storage disorder caused by alpha-galactosidase A (alpha-GAL A) deficiency.

25 ed lysosomal storage disease caused by alpha-galactosidase A (alpha-Gal A) deficiency.

26 Clinical assessments, alpha-galactosidase A (alpha-GalA) activities, glycosphingolip

27 neumoniae mutants deficient in NanA and beta-galactosidase A (BgaA) failed to form biofilms in vivo d

28 A gene knockout (Gla KO) mice have no alpha-galactosidase A activity and progressively accumulate GL

29 ype observed in patients with residual alpha-galactosidase A activity.

30 ase is caused by deficient activity of alpha-galactosidase A and subsequent accumulation of glycosphi

31 isease caused by deficient activity of alpha-galactosidase A and the resultant systemic accumulation

32 torage disorder caused by a deficit in alpha-galactosidase A enzyme activity leading to glycosphingol

33 Leukocyte alpha-galactosidase A enzyme activity was mildly reduced in 19

34 alpha-Galactosidase A gene knockout (Gla KO) mice have no alph

35 of the N215S (c.644A>G [p.Asn215Ser]) alpha-galactosidase A gene variant.

36 We studied whether cardio-specific alpha-galactosidase A gene variants are misinterpreted as hype

37 inked Fabry disease (FD) caused by GLA(alpha-galactosidase A gene) mutations encoding p.D322E (family

38 alpha-Galactosidase A genotype N215S does not lead to the deve

39 distribution of selected glycoforms of alpha-galactosidase A in a Fabry disease mouse model, and find

40 Defects in the gene encoding alpha-galactosidase A lead to accumulation of globotriaosylcer

41 bry rat eyes accumulated substrates of alpha-galactosidase A, and these alpha-galactosyl glycoconjuga

42 r caused by a deficiency of the enzyme alpha-galactosidase A, which results in the progressive accumu

43 aimed to evaluate ocular phenotypes in alpha-galactosidase A-deficient (Fabry) rats and hypothesized

44 M., alpha-Galactosidase A-deficient rats accumulate glycosphingoli

45 b3Cer) in the kidneys of wild-type and alpha-galactosidase A-knockout (Fabry) mice was possible at ab

46 deficient activity of lysosomal enzyme alpha-galactosidase A.

47 se, which is caused by a deficiency in alpha-galactosidase A.

48 torage disease caused by deficiency of alpha-galactosidase A.

49 increases in senescence associated (SA) beta-galactosidase, a known marker of cellular senescence.

50 beta-galactosidase, a lysosomal protein, was elevated 3.6-5.7

51 chitosan silver nanocomposite adsorbed beta-galactosidase, a multi-fold enhancement in catalytic act

52 en fluorescent protein (GFP)-AAP2BR and beta-galactosidase-AAP2BR fusion proteins, respectively, and

53 markers including senescence-associated beta-galactosidase, accumulation of cytosolic p16(INK4A) and

54 39% reduction in senescence-associated beta-galactosidase activity (p < 0.01) but no changes in telo

55 ere imaged with and without a stain for beta-galactosidase activity (S-Gal + ferric ammonium citrate)

56 We also found high beta-galactosidase activity accompanying tension wood differe

57 sults indicate that the lack of exo-beta-1,3-galactosidase activity alters cell wall extensibility in

58 ence, verified by senescence-associated beta-galactosidase activity and cell cycle markers p16 and p2

59 the induction of senescence-associated beta-galactosidase activity and cell morphology.

60 Analysis of beta-galactosidase activity and controlled release reveals th

61 aponins effects on Kluyveromyces lactis beta-galactosidase activity and correlated these changes to t

62 the induction of senescence-associated beta-galactosidase activity and flat cell morphology.

63 by an increase in senescence-associated beta-galactosidase activity and formation of senescence-assoc

64 s effectively demonstrated in vitro for beta-galactosidase activity and in vivo in a mouse model of i

65 lls showed higher senescence-associated beta-galactosidase activity and increased gene expression of

66 totic but displayed senescence associated-ss-galactosidase activity and upregulated p16, indicating p

67 dase activity, membrane permeability, <beta>-galactosidase activity and, therefore, less softening af

68 and procedure for the determination of beta-galactosidase activity are proposed.

69 spectively, which by their lacZ encoded beta-galactosidase activity convert the inactive prodrug Daun

70 beta-Galactosidase activity decreased in the presence of tann

71 porter assay linking LasR function with beta-galactosidase activity gave results consistent with thos

72 cent probes for imaging caspase-3/7 and beta-galactosidase activity in live cells.

73 taGal sensitively detects intracellular beta-galactosidase activity in several ovarian cancer lines.

74 in Escherichia coli yields significant beta-galactosidase activity in vivo from a lacZ gene containi

75 Some cerebral LLC exhibited beta galactosidase activity indicating a senescence phenotype

76 developmental stage- and cell-specific beta-galactosidase activity mimicking the endogenous amelogen

77 GH43 variants revealed that the exo-beta-1,3-galactosidase activity of GH43 enzymes is hindered by be

78 e was assessed as senescence-associated beta-galactosidase activity using flow cytometry, oxidative s

79 ells positive for senescence-associated beta-galactosidase activity was also evident with chronic IH

80 beta-Galactosidase activity was detected in osteocytes of sos

81 ion relationships underpinning the alpha-1,3-galactosidase activity within family GH110 remain unknow

82 e senescence, as indicated by increased beta-galactosidase activity, elevated CDKN1A mRNA expression,

83 ined by a rise in senescence-associated beta-galactosidase activity, higher abundance of CDKN1A/P21 a

84 splayed increased senescence-associated beta-galactosidase activity, lower average telomere lengths b

85 induced increased senescence-associated beta-galactosidase activity, oxidative stress, early phosphor

86 ed with decreased senescence-associated beta-galactosidase activity, preserved telomere length, reduc

87 erative capacity, senescence-associated beta-galactosidase activity, the known senescence-inducing pa

88 e, as assessed by senescence-associated beta-galactosidase activity, was induced by the passaging of

89 sing the novel phenotype of periplasmic beta-galactosidase activity, we show that the periplasmic cha

90 ll morphology and senescence-associated beta-galactosidase activity.

91 y become senescent, as determined by SA-beta-galactosidase activity.

92 est and increased senescence-associated beta-galactosidase activity.

93 cence and express senescence-associated beta-galactosidase activity.

94 equence caused an 8.6-fold reduction in beta-galactosidase activity.

95 nescence-related proteins p53, p16, and beta-galactosidase activity.

96 N2A proteins, and senescence-associated beta-galactosidase activity.

97 xpression and secretion, DNA damage and beta-galactosidase activity; unfortunately, these traits are

98 initiating enzyme in this pathway, the alpha-galactosidase Aga (a family 36 glycoside hydrolase), can

99 ut also able to protect a model enzyme (beta-galactosidase) against lyophilization and heat challenge

100 oviruses (genogroup III) interact with alpha-galactosidase (alpha-Gal) carbohydrates, and murine noro

101 s possibly involved in apple softening, beta-galactosidase, alpha-arabinofuranosidase, polygalacturon

102 lysis in Arabidopsis: alpha-xylosidase, beta-galactosidase, alpha-fucosidase, soluble beta-glucosidas

103 and 4 inhibit the two human retaining alpha-galactosidases alphaGal A and alphaGal B covalently and

104 an only be detected and qualified after beta-galactosidase and beta-N-acetylhexosaminidase digestion.

105 beta-Galactosidase and beta-N-acetylhexosaminidase were used

106 ation and crosslinking (combi-CLEAs) of beta-galactosidase and glucose isomerase for catalyzing the c

107 -ON probes for detection and imaging of beta-galactosidase and hydrogen peroxide.

108 ified the molecular interaction between beta-galactosidase and o-nitrophenyl-beta-d-galactoside, redu

109 increased senescence-associated markers beta-galactosidase and p16 mRNA in aged CPCs.

110 e of a complex between Escherichia coli beta-galactosidase and the cell-permeant inhibitor phenylethy

111 onstrated with the accurate modeling of beta-galactosidase and TRPV1 proteins at 3.2 A and 3.4 A reso

112 New alpha-galactosidases and alpha-N-acetylgalactosaminidases were

113 multiple proteins (e.g. BSA, HSA, GOx, beta-galactosidase) and monomer classes including acrylates,

114 hexosaminidase, galactosylceramidase, alpha-galactosidase, and beta-galactosidase) mediating glycosp

115 es, namely beta-glucosidase, invertase, beta-galactosidase, and catalase, are encapsulated in ZIF-8,

116 luding p16, EGFP, senescence-associated beta-galactosidase, and the senescence-associated secretory p

117 40-50% with B. circulans and A. oryzae beta-galactosidases, and at 95% lactose depletion for K. lact

118 e a fluctuation type of distribution of beta-galactosidase appearance in a growing culture, consisten

119 hydrolysis of RFOs increase the Cicer alpha-galactosidase application in food processing industries.

120 solution structure of Escherichia coli beta-galactosidase ( approximately 465 kDa), solved at approx

121 panies the use of senescence-associated beta-galactosidase as a collection of semiselective markers t

122 ed with adenoviruses containing A20 (or beta-galactosidase as a control) were allografted into major

123 gene used as recognition elements with beta-galactosidase as the reporter protein was designed and a

124 nhibition of the hydrolytic activity of beta-galactosidase (Aspergillus oryzae) was evaluated.

125 we established a senescence associated beta-galactosidase assay as a screening platform to rapidly i

126 d dramatically the dynamic range of the beta-galactosidase assay for cadBA activation.

127 Using Northern hybridization and beta-galactosidase assays of an ace promoter-lacZ fusion, we

128 cytotoxicity and senescence-associated beta-galactosidase assays, which were compared with dissolved

129 osomal enzymes (alpha-glucosidase (AG), beta-galactosidase (B-GAL) and beta-N-acetylglucosamidase (B-

130 uring treatment with several commercial beta-galactosidases (Bacillus circulans, Kluyveromyces lactis

131 ant was also 'leaking' as revealed by a beta-galactosidase-based assay employing a membrane impermeab

132 Mutations in the galactosidase beta 1 (GLB1) gene cause lysosomal beta-ga

133 Autosomal recessive mutations in the galactosidase beta 1 (GLB1) gene cause lysosomal beta-ga

134 alpha-l-arabinofuranosidase (AFase) and beta-galactosidase (beta-Gal) activities, resulting in prefer

135 the DeltabioR DeltabioBFDA mutant), the beta-galactosidase (beta-Gal) activity of three plasmid-borne

136 h amounts of galactose and considerable beta-galactosidase (beta-Gal) activity was observed.

137 beta-galactosidase (beta-gal) and beta-glucuronidase (beta-gl

138 was implemented into the procedure with beta-galactosidase (beta-gal) as the detection enzyme.

139 dase beta 1 (GLB1) gene cause lysosomal beta-galactosidase (beta-Gal) deficiency and clinical onset o

140 dase beta 1 (GLB1) gene cause lysosomal beta-galactosidase (Beta-Gal) deficiency, resulting in accumu

141 iated lysis was used to release endemic beta-galactosidase (beta-gal) from the bound bacterial cells;

142 In these animals, staining for beta-galactosidase (beta-gal) identifies cells in which NF-ka

143 We demonstrate that when beta-galactosidase (beta-gal) is expressed in LECs, beta-gal-

144 k, specific immobilization of 6-phospho-beta-galactosidase (beta-Gal) on a self-assembled monolayer (

145 beta-Galactosidase (beta-gal), one of the typical lysosomal g

146 - i) bovine serum albumin (BSA) and ii) beta-galactosidase (beta-gal), was investigated by micro-flow

147 yme activity in mouse models expressing beta-galactosidase (beta-gal).

148 12, which expresses the omega-domain of beta-galactosidase (beta-gal).

149 icles and free antibodies conjugated to beta-galactosidase (beta-gal).

150 ngineered with lacZ operon encoding for beta-galactosidase (beta-gal).

151 osidase/beta-xylosidase that also shows beta-galactosidase, beta-fucosidase, alpha-arabinofuranosidas

152 zymes involved in cell wall metabolism (beta-galactosidase, beta-glucosidase, beta-amylase, chitinase

153 Autosomal recessive mutations in the galactosidase beta1 (GLB1) gene cause lysosomal beta-gal

154 reduction or absence of lysosomal acid beta-galactosidase (betagal) activity.

155 Using beta-galactosidase (betagal) as a model system, we have emplo

156 to cell fate reporter mice that express beta-galactosidase (betagal) in cells of AEC lineage.

157 Mice expressing beta-galactosidase (betagal) on a retina-specific promoter (b

158 ew model of memory inflation based on a beta-galactosidase (betagal)-recombinant adenovirus vector.

159 ides 7a-e and 8 were found to be modest beta-galactosidase (bGal) inhibitors.

160 M4), to express the cell wall modifying beta-galactosidase (BGAL)-encoding gene MUCILAGE-MODIFIED2 (M

161 bation of BoMan26B and the periplasmic alpha-galactosidase BoGal36A increased the rate of galactose r

162 ses, BoMan26A and BoMan26B, and a GH36 alpha-galactosidase, BoGal36A.

163 of tannic acid on Kluyveromyces lactis beta-galactosidase catalytic activity and correlate these cha

164 e tit1+ and tit1-Delta cells by using a beta-galactosidase codon-swap reporter whose catalytic activi

165 In the current study we used a beta-galactosidase complementation method to screen a selecti

166 PCR assay to detect NWM SFV DNA, and a beta-galactosidase-containing indicator cell line to assay re

167 The hydrolysis of lactose over beta-galactosidase converted 95.77 +/- 0.67% of lactose into

168 Importantly, endo-beta-galactosidase coupled with MALDI-MS allowed these two ep

169 ase, an X-linked disorder of lysosomal alpha-galactosidase deficiency, leads to substrate accumulatio

170 cheal delivery of AAV1 was confirmed by beta-galactosidase detection in the distal pulmonary vasculat

171 gene and lacz reporter cDNA coding for beta-galactosidase directed by the CerS6 promoter.

172 l of oligonucleotides to the surface of beta-galactosidase enhances its cellular uptake of by up to a

173 tal pattern with the LacZ gene encoding beta-galactosidase enzyme activity assay and Cre protein immu

174 Monastrell wines were also treated with beta-galactosidase enzyme addition and commercial enzyme addi

175 ques (cold pre-fermentative maceration, beta-galactosidase enzyme addition and enzymatic preparation

176 d by hydrolyzing native guar gum using alpha-galactosidase enzyme.

177 beta-Galactosidase enzymes are used in the dairy industry to

178 istinct profile of senescence including beta-galactosidase expression, autofluorescence, growth inhib

179 ting in decreased senescence-associated beta-galactosidase expression, increased self-renewal potenti

180 vasive imaging of Hmox1 expression, and beta-galactosidase for high-resolution mapping of expression

181 t 50 of the 67 participants had mutant alpha-galactosidase forms suitable for targeting by migalastat

182 The initial assay of mutant alpha-galactosidase forms that we used to categorize 67 patien

183 andomly assigned patients (with mutant alpha-galactosidase forms that were suitable or not suitable f

184 alysis, involving patients with mutant alpha-galactosidase forms that were suitable or not suitable f

185 beta-Galactosidase formulations can be added to infant milks

186 lised in the development and testing of beta-galactosidase formulations.

187 hia coli l-arabinose promoter and bgaB (beta-galactosidase from Bacillus stearothermophilus) to creat

188 viously described the first beta-(1,6)/(1,3)-galactosidase from Bifidobacterium animalis subsp. lacti

189 ctans from acacia gum by a galactan-beta-1,3-galactosidase from family GH43; however, while B. thetai

190 ifferent GOS profiles of the commercial beta-galactosidases from Bacillus circulans, Kluyveromyces la

191 rization of two Golgi-localized exo-beta-1,3-galactosidases from the glycosyl hydrolase 43 (GH43) fam

192 using six cryo-EM structures of TRPV1, beta-galactosidase, gamma-secretase, ribosome-EF-Tu complex,

193 as able to image cells transfected with beta-galactosidase gene by chemiluminescence microscopy.

194 type RIMD2210633 strain marked with the beta-galactosidase gene lacZ (WBWlacZ), the mutant colonized

195 rpoE mutant and the WT marked with the beta-galactosidase gene lacZ (WBWlacZ), the mutant strain was

196 either the BMP inhibitor noggin or the beta- galactosidase gene under the control of a BMP-responsive

197 of the human coagulation factor IX and alpha-galactosidase genes into endogenous genomic loci with hi

198 n (Psap), Niemann Pick type C2 (Npc2), alpha-galactosidase (Gla), are up-regulated in early adipogene

199 alpha-galactosidase has been shown to reduce gas production an

200 orm, we could investigate the levels of beta-galactosidase in cells grown under different nutrient co

201 se factors on the performance of enzyme beta-galactosidase in formulations for reduction of levels of

202 eling in Pw1(nLacZ+/-) mouse expressing beta-galactosidase in PW1(+) cells and in differentiated cell

203 luate the efficacy and tolerability of alpha-galactosidase in the treatment of gas-related symptoms i

204 alytical system allows determination of beta-galactosidase in the wide range of activity (up to 15 U/

205 hat could be explained by the involvement of galactosidases in AGP glycan biosynthesis.

206 ion of the endogenous activity of both alpha-galactosidases in cell extracts, thereby providing a mea

207 enescence such as senescence-associated beta-galactosidase, increased p21 expression, micronuclei for

208 e, stabilizes specific mutant forms of alpha-galactosidase, increasing enzyme trafficking to lysosome

209 f treated cells also stain positive for beta-galactosidase, indicating senescence.

210 rent origins (isoenzymes), detection of beta-galactosidase inhibitor and finally to the determination

211 ounds, 4-epi-fagomine (2b) was the best beta-galactosidase inhibitor, and it also prevented LPS-media

212 ose-free food and controlled release of beta-galactosidase into lactose-intolerant individuals.

213 Apoptosis (AIDA)) whereby a single anti-beta-galactosidase intracellular single chain Fv antibody fra

214 beta-d-Galactosidase is an important enzyme in the dairy indust

215 a genetic circuit in which synthesis of beta-galactosidase is under control of the arsenite-derepress

216 beta-Galactosidase is vital to dairy industries because it ca

217 ide and a constant amount of the enzyme beta-galactosidase, is produced at frequencies in excess of 1

218 BdBGAL1, unlike other xyloglucan beta-galactosidases, is able to remove both galactoses from X

219 ostin (sost) gene was replaced by the beta-D-galactosidase (lacZ) gene in the germ line.

220 completely account for the increase in beta-galactosidase levels in mutT lacZamber cultures, without

221 addition, we found that serum LAMP1 and beta-galactosidase levels were significantly decreased in pre

222 cts, elevation of senescence-associated beta-galactosidase levels, and changes in gene expression clo

223 pe IV collagen was investigated, but no beta-galactosidase-like activity capable of collagen modifica

224 a platform to immobilize Lens culinaris beta-galactosidase (Lsbgal) which resulted in 93% of immobili

225 sylceramidase, alpha-galactosidase, and beta-galactosidase) mediating glycosphingolipid hydrolysis we

226 Xylosidase and galactosidase mutants were complemented, respectively, b

227 examined STOML1 null mutant mice with a beta-galactosidase-neomycin cassette gene-trap reporter drive

228 ine chitosan silver nanocomposite bound beta-galactosidase on addition of metal ions as compared to t

229 nctional vascular graft by immobilization of galactosidase on the graft surface.

230 arly, pretreating neutrophils with endo-beta-galactosidase or neuraminidase converted ANCA assay resu

231 ts treated with a control AAV1 carrying beta-galactosidase or saline.

232 on with rats administered AAV1 carrying beta-galactosidase or saline.

233 etected in immune cells of C57BL/6, BRE-beta-galactosidase, or BMP-4(betagal/+) mice.

234 hibit an elevated VEGF, localization of beta-galactosidase outside the subventricular zone (SVZ), sub

235 lular senescence-related genes, such as beta-galactosidase, p21, p53, and gammaH2AX, and mTOR/pS6 sig

236 lactulose was performed with commercial beta-galactosidase preparations from Aspergillus oryzae, Kluy

237 beta-Galactosidase promotes the isomerization by means of an

238 spase-3 after binding to the tetrameric beta-galactosidase protein.

239 t with the deglycosylating enzyme, endo-beta-galactosidase, reduced the mass of neutrophil hLAMP-2 to

240 n expressing a disulfide-bond sensitive beta-galactosidase reported previously.

241 AR2 and PDI1 mRNAs, and expression of a beta-galactosidase reporter activated by Hac1(i) Phosphorylat

242 icide A (GCA) inhibited HSV-1 entry via beta-galactosidase reporter assay and impaired incoming virus

243 entry and infection, as measured by the beta-galactosidase reporter assay.

244 t mice overexpressing human HB-EGF with beta-galactosidase reporter exhibit an elevated VEGF, localiz

245 Expression of the bacterial beta-galactosidase reporter gene (lacZ) in the vector used fo

246 ed pCTEN-Cre:R26R mice by crossing R26R beta-galactosidase reporter mice with pCTEN-Cre transgenic mi

247 a premature UAG stop codon located in a beta-galactosidase reporter.

248 splicing, induction of KAR2, PDI1, and beta-galactosidase reporters, and survival of ER stress, but

249 amagnetic NiL(1) and NiL(2) by light or beta-galactosidase, respectively, converts them into paramagn

250 DNA-functionalized beta-galactosidase retains its ability to catalyze the hydrol

251 ed proliferation, senescence-associated beta-galactosidase (SA-beta-gal) activation, and increased mR

252 S) production and senescence-associated beta-galactosidase (SA-beta-gal) activity but an increase in

253 n; an increase in senescence-associated beta-galactosidase (SA-beta-Gal) activity, a marker of cellul

254 rked by increased senescence-associated beta-galactosidase (SA-beta-Gal) staining and gammaH2AX-posit

255 escence marked by senescence-associated beta-galactosidase (SA-beta-gal), p16Ink4a, and p53 in lamin

256 lat, enlarged and senescence-associated beta-galactosidase (SA-beta-Gal)-positive cells.

257 (DDR) signaling, senescence-associated beta-galactosidase (SA-betagal) activity, increased expressio

258 ers p21(CIP1/WAF1), senescence-associated ss-galactosidase (SA-ss-gal), and p16(INK4a) were increased

259 rn-on" ratio upon senescence-associated beta-galactosidase (SABG) activation.

260 An anti-beta-galactosidase scFv:MOG fusion protein (scFv GL117:MOG) s

261 stant acid phosphatase histoenzymology, beta-galactosidase, sclerostin immunochemistry, and terminal

262 ichroism shows that saponin changes the beta-galactosidase secondary structure, favoring its protein-

263 (addition of enzymatic preparation and beta-galactosidase separately and dry ice addition) may affec

264 alpha-galactosidase significantly reduced global distress (p =

265 xyloglucan, including alpha-xylosidase, beta-galactosidase, soluble and membrane-bound beta-glucosida

266 was evaluated by senescence-associated beta-Galactosidase staining and by Western blot analysis of p

267 showed increased senescence-associated beta-galactosidase staining and increased senescence-associat

268 ver tissue and by senescence-associated beta-galactosidase staining in a culture-based model of insul

269 KLK4 protein levels in rat enamel and beta-galactosidase staining in LacZ-C57BL/6-Klk4 (+/LacZ) mou

270 ce, determined by senescence-associated beta-galactosidase staining, was obviously attenuated by p38-

271 By beta-galactosidase staining, we demonstrated that Mig-6 was u

272 ofluorescence and senescence-associated beta-galactosidase staining.

273 nderstand the effects of tannins on the beta-galactosidase structure and how they are related to the

274 fundi harbors a model polyextremophilic beta-galactosidase that functions in cold, hypersaline condit

275 of marine bacterial exo-alpha-3,6-anhydro-d-galactosidases that have specific activity on red algal

276 The effect of beta-galactosidase to glucose isomerase activity ratio and gl

277 s exoglycosidases, one of which is BgaC beta-galactosidase, to deglycosidate host surface glycolconju

278 We found that beta-galactosidase translocation is driven only by the negati

279 sed approach to quantify pep-1-mediated beta-galactosidase translocation.

280 02 in the LHb previously transfected with ss-galactosidase under control of the FosB promoter.

281 Daun02 in the dlBST previously expressing ss-galactosidase under control of the FosB/DeltaFosB promot

282 6/lacZ reporter mouse strain expressing beta-galactosidase under the control of the Mig-6 gene promot

283 hydrolysis by the immobilized K. lactis beta-galactosidase using genipin as a crosslinker was 87%.

284 wn mRNA of a selected chromosomal gene (beta-galactosidase) using an artificial miniCRISPR locus.

285 aximum GOS concentration with K. lactis beta-galactosidase was achieved in 1 and 5h at 40 and 4 degre

286 Initially, beta-galactosidase was employed as a detectable model for BT

287 Cicer alpha-galactosidase was immobilized onto functionalized graphe

288 Finally, the expression level of beta-galactosidase was significantly higher when point mutati

289 ke growth factor binding protein 7, and beta-galactosidase were able to distinguish the severe neurol

290 activity of two commercially available beta-galactosidases were investigated.

291 ed alpha2-3 sialidase, followed by beta1-3,4 galactosidase, which cleaved any terminal alpha2-3-linke

292 Here we focus on beta-galactosidase, which is overexpressed in primary ovarian

293 wn of some lactose and the provision of beta-galactosidase, which remains active in the gastrointesti

294 alytic ability of the hydrolytic enzyme beta-galactosidase, which serves as the protein core, despite

295 cells with HHV-8 induces expression of beta-galactosidase, which was used to determine TCID50 levels

296 Among patients with suitable mutant alpha-galactosidase who received migalastat for up to 24 month

297 ect enzyme activity for the reaction of beta-galactosidase with p-aminophenyl-galactopyranoside (PAPG

298 that saponins increased the affinity of beta-galactosidase with the artificial substrate o-nitropheny

299 Kanzi apples had lower activity of beta-galactosidase, with no decline in the extent of branchin

300 the marine bacterial exo-alpha-3,6-anhydro-d-galactosidase ZgGH129 demonstrates that the minimum subs